Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes ...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...

Although existing treatments allow a full life with the HIV virus, now, more than ever, scientists are close to developing a mechanism that will completely remove the virus from the body.

Tigers are the largest cat species. The subspecies called Amur tigers, also known as Siberian tigers, are the biggest of ...

Asahi Kasei has agreed a €780 million (around $920 million) price tag for Wuppertal-based Aicuris, which is hoping for FDA ...

Hidden within cancer DNA data, researchers uncovered viruses and bacteria that may influence both diagnosis and survival.

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively ...

In a bid to safeguard public health and ensure food safety, the Saudi Food and Drug Authority has enacted a total ban on ...

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty pharmaceutical platform.

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approxima ...

Mirum Pharmaceuticals reported strong FY 2025 revenues, capping an exceptional year of growth and pipeline expansion. Learn more about MIRM stock here.